Kinex Pharmaceuticals Management

About Us Team Pipeline News Contact Us Home
Kinex raises more than $3 million in equity financing

Kinex Co-Founder Appointed to NYBA Board

Kinex Awarded US Patent

Start of Clinical Trial for KX2-391

KX2-391 Enters Phase 1 Clinical Trials for Oncology

More headlines ...

Management Team


David Hangauer, Ph.D.
Senior Vice President
Research & Development
dhangauer@kinexpharma.com

Dr. Hangauer is a leader in the field of structure based drug design. Following graduate studies at the University at Buffalo, he spent ten years at Merck Sharp and Dohme Research Laboratories where he directed a variety of drug discovery projects. In 1989, Dr. Hangauer returned to academia and joined the chemistry faculty at SUNY Buffalo where he has had a productive career that has focused on developing protein kinase inhibitors.

Dr. Hangauer's expertise is highly sought by pharmaceutical and biotechnology companies worldwide, underscoring his level of expertise and his recognition as a major contributor to commercial drug discovery efforts.